ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0614

Self-Reported Sexual Dysfunction and Perceptions of Rheumatologist Engagement on This Issue in Patients with Systemic Sclerosis

Liza Morales1, Robert Spiera2, Jessica Gordon1, Deanna Jannat-Khah1 and Kimberly Lakin1, 1Hospital for Special Surgery, New York, NY, 2Hosptial for Special Surgery, New York, NY

Meeting: ACR Convergence 2023

Keywords: Scleroderma, Scleroderma, Systemic, Sexual Function, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Few studies have investigated the prevalence and risk factors of sexual dysfunction among individuals with systemic sclerosis (SSc). The purpose of this study is to define, among individuals with SSc, (1) the prevalence and risk factors associated with sexual dysfunction, (2) the frequency of discussions regarding this subject, and (3) patient-perceived barriers to those discussions.

Methods: We developed the Sexual Function in SSc Questionnaire (SFSScQ) to anonymously survey individuals with self-reported SSc regarding their sexual function and sexual health discussions with their MD rheumatologist. Participants were asked to complete the SSFSScQ and to complete the Female Sexual Function Index (FSFI) or the International Index of Erectile Function (IIEF) Questionnaire based on self-reported sex. Participant characteristics between those with vs. without self-reported sexual dysfunction were compared using Fisher’s Exact test. Agreement to statements regarding potential barriers to sexual function conversations were compared between those who reported feeling satisfied vs. not satisfied with sexual health discussions using Fisher’s Exact test. Univariable and multivariable logistic regression were performed to assess factors associated with sexual dysfunction.

Results: 41 participants completed the SFSScQ; 30 (73%) also completed the FSFI or IIEF. 26 (63%) participants reported sexual dysfunction. Clinical characteristics of those with vs. without self-reported sexual dysfunction are shown in Table 1. In both unadjusted and adjusted regression models, age, sex, race, SSc subtype, and time since SSc diagnosis were not predictors of sexual dysfunction. Self-reported sexual dysfunction was not associated with the presence of sexual dysfunction on the scored questionnaires (p=0.431); 25% of individuals who self-reported sexual dysfunction did not meet scored questionnaire criteria (Table 2). 36 (88%) of 41 participants had never discussed sexual health with their rheumatologist, of whom 23 (64%) self-reported sexual dysfunction. 19 (46.3%) participants agreed that having conversations with their rheumatologist regarding sexual function was important. Most (33 (81%)) were not satisfied with the sexual health discussions they have had to-date (Table 3). Patients who were satisfied (vs. not satisfied) with their sexual health discussions more often felt comfortable discussing sexual function with their rheumatologist (p=0.012), believed their rheumatologist makes time to discuss sexual function (p=0.003), and felt that their rheumatologist has been helpful regarding sexual function (p=0.002) (Table 3).

Conclusion: A majority of participants with self-reported SSc indicated that they experience sexual dysfunction but have never discussed sexual health with their rheumatologist. No patient-level factors were identified as independent predictors of sexual dysfunction; however, our sample size is small. Self-reported sexual dysfunction was not associated with sexual dysfunction determined by scored questionnaires, suggesting that SSc sexual dysfunction may encapsulate disease specific complaints not captured by surveys designed for other populations.

Supporting image 1

Table 1. Bivariate comparison between participants with systemic sclerosis who self-reported sexual dysfunction and participants who did not by characteristics and demographics.

Supporting image 2

Supporting image 3


Disclosures: L. Morales: None; R. Spiera: AbbVie/Abbott, 2, 5, Amgen, 2, AstraZeneca, 5, chemocentryx, 5, corbus, 5, Formation Biologics, 5, GSK, 2, 5, Inflarx, 5, Kadmon, 5, Novartis, 2, 5, Principia, 5, Sanofi, 2; J. Gordon: Cumberland Pharmaceuticals, 5, Prometheus Pharmaceuticals, 5; D. Jannat-Khah: AstraZeneca, 12, stock ownership, Cytodyn, 12, stock ownershil[, Walgreens Boots Alliance, 12, stock ownership; K. Lakin: None.

To cite this abstract in AMA style:

Morales L, Spiera R, Gordon J, Jannat-Khah D, Lakin K. Self-Reported Sexual Dysfunction and Perceptions of Rheumatologist Engagement on This Issue in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/self-reported-sexual-dysfunction-and-perceptions-of-rheumatologist-engagement-on-this-issue-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-reported-sexual-dysfunction-and-perceptions-of-rheumatologist-engagement-on-this-issue-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology